340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

Big Pharma Plays the Blame Game on Drug Prices


 

Print Article

March 2, 2017—If you’re in business, it’s bad news when the president of the United States asks a joint session of Congress on national TV to do something immediately about your “artificially high” prices.

That’s the situation Big Pharma is in today. President Trump’s jab about its price gouging in his Feb. 28 congressional address is just the latest he’s taken at the industry. The media is piling on, too. Every day there’s another headline about a drug company gaming the system to goose its profits or a patient forced to choose between obscenely expensive medicine and food, clothing, and shelter.

How has Big Pharma responded? By blaming others for making it set prices sky high. The 340B drug discount program is a favorite scapegoat. “The logic goes thusly: Since pharmaceutical companies must provide discounted medicines to 340B hospitals, they automatically raise prices on those drugs for everyone else to make up the difference,” write the directors of two cancer centers that depend on 340B savings in a new Morning Consult op-ed. “The problem? There are absolutely no data to back up the assertion. Even at a 20 to 50 percent discount to safety-net providers, drug makers often enjoy a sizeable profit. How much? We’ll never know because they guard that secret like the crown jewels.”

“We work for safety-net hospitals and it’s our mission to treat all patients who come through our doors,” write Dr. Mary Margaret Kemeny and Dr. Robert Chapman (the former is director of the Queens Cancer Center of Queens Hospital in Jamaica, N.Y.; the latter is director of the Josephine Ford Cancer Institute at the Henry Ford Health System in Detroit). “Savings from the 340B program help us provide diagnosis, medications and surgery to uninsured and underinsured individuals who would certainly die without medical intervention….And yet the drug industry continues to try and gut the program.”

Big Pharma’s $100 million ad campaign to restore its battered image “could buy 1,639,344 vials of cisplatin 50mg treatments for breast, ovarian, bladder and testicular cancer,” the physicians note.

“Imagine how many lives that could save.”

Recent Articles

  • HRSA Still Plans to Start Enforcing New 340B Regulation on April 1
  • Big Pharma Plays the Blame Game on Drug Prices
  • Report: Patient Groups Mum on High Drug Costs

Follow us on Twitter

340B HealthFollow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340B Health
340BHealth340B Health@340BHealth·
10h

.@BosBizJournal reports that @HRSAGov sent @Merck a letter stating the company’s restrictions on discounts to safety-net hospitals are in violation of federal law. via @cassiemcgrath_: https://bit.ly/3yJgXqj #340B #Protect340B #Mapoli $MRK

Reply on Twitter 1527405393776889862Retweet on Twitter 1527405393776889862Like on Twitter 1527405393776889862Twitter 1527405393776889862
340BHealth340B Health@340BHealth·
13h

Patients shouldn’t have to jump over hurdles to access #healthcare services and discounts on vital medications. But that is what 16 #pharma companies are forcing them to do. Learn more: http://www.stop340bcuts.org #340B #Protect340B

Reply on Twitter 1527371531575525376Retweet on Twitter 1527371531575525376Like on Twitter 1527371531575525376Twitter 1527371531575525376
340BHealth340B Health@340BHealth·
17h

#340B savings fund programs at safety-net hospitals to help patients manage #asthma. These hospitals treat more low-income patients with the disease than non-340B hospitals. Learn more: https://bit.ly/3ll3tt2 #Protect340B #AsthmaMonth

Reply on Twitter 1527307653252149249Retweet on Twitter 15273076532521492491Like on Twitter 15273076532521492492Twitter 1527307653252149249
Load More...

RSS 340B Informed

  • With 340B Pricing Restrictions, Hospitals Are Facing Double the Trouble
  • Faces of 340B: Community Pharmacy Partnerships Aid in the Cancer Care Cause
  • 340B Community Pharmacy Legal Battle Moves to Next Stage

Copyright © 2022 · 340B Health